novel treatment strategies in low-risk mds: case study
Published 2 years ago • 184 plays • Length 18:42Download video MP4
Download video MP3
Similar videos
-
18:14
novel treatment strategies in low-risk mds: challenges and emerging therapies
-
14:55
novel treatment strategies in low-risk mds: q&a
-
29:39
novel strategies to prevent relapse after allogeneic transplantation for mds
-
21:55
a unified approach to lower risk mds: standard and emerging therapies
-
24:04
my approach to mds management
-
33:47
my approach to mds management
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
4:12
novel therapies in low-risk mds
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
10:11
novel agents and treatment strategies in myelodysplastic syndromes
-
1:25
novel strategies for treating cytopenia in mds
-
20:13
debate: hypomethylating agents are appropriate in lower-risk mds - only use with caution
-
23:17
erythropoiesis stimulating agents and other growth factors in low-risk mds: an update
-
11:33
treatment algorithm for low-risk mds
-
0:56
the promise of luspatercept for the treatment of lower-risk mds
-
2:21
how is lower-risk mds treated?
-
1:27
novel targets in low-risk mds
-
19:11
novel agents and combination therapies in myelofibrosis
-
18:42
case discussion: high-risk myelodysplastic syndromes